Abstract
Hydrogen sulfide (H(2)S) is the third gasotransmitter and is generated endogenously in hypoxic or inflammatory tissues and various cancers. We have recently demonstrated that endogenous H(2)S can be imaged with [(99m)Tc]Tc-gluconate. In the present study, we detected H(2)S generated in hypoxic tissue, both in vitro and in vivo, using [(99m)Tc]Tc-gluconate. In vitro uptake of [(99m)Tc]Tc-gluconate was measured under hypoxic and normoxic conditions, using the colon carcinoma cell line CT26, and was higher in hypoxic cells than that in normoxic cells. An acute hindlimb ischemia-reperfusion model was established in BALB/c mice by exposing the animals to 3 h of ischemia and 3 h of reperfusion prior to in vivo imaging. [(99m)Tc]Tc-gluconate (12.5 MBq) was intravenously injected through the tail vein, and uptake in the lower limb was analyzed by single-photon emission computed tomography/computed tomography (SPECT/CT). SPECT/CT images showed five times higher uptake in the ischemic limb than that in the normal limb. The standard uptake value (SUVmean) of the ischemic limb was 0.39 ± 0.03, while that of the normal limb was 0.07 ± 0.01. [(99m)Tc]Tc-gluconate is a novel imaging agent that can be used both in vitro and in vivo for the detection of endogenous H(2)S generated in hypoxic tissue.